|Articles|May 17, 2004

Hospitals start pilot testing RFID to curb drug diversion

M.D. Anderson Cancer Center in Houston is testing RFID on two medications, Neupogen (filgrastim, Amgen) and Procrit (epoetin alfa, Ortho Biotech).

Related to this article